TransMedics Group Inc (TMDX)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 35,780 | -26,671 | -36,165 | -44,179 | -28,716 |
| Revenue | US$ in thousands | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
| Pretax margin | 8.10% | -11.04% | -38.70% | -145.99% | -112.00% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $35,780K ÷ $441,540K
= 8.10%
TransMedics Group Inc's pretax margin has displayed fluctuations over the years. The company reported negative pretax margins in 2020, 2021, and 2022 at -112.00%, -145.99%, and -38.70% respectively, indicating that its operating expenses and costs were surpassing its revenues. However, there was a notable improvement in 2023 when the pretax margin improved to -11.04%, moving closer to break-even. This positive trend continued in 2024, with a pretax margin of 8.10%, reflecting a turnaround in profitability as the company managed to generate more income before taxes relative to its revenue. This improvement suggests that TransMedics Group Inc may have implemented cost-cutting measures or revenue-enhancing strategies leading to better financial performance.
Peer comparison
Dec 31, 2024